27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
NEW ORLEANS, Dec. 8, 2019 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until December 9, 2019 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company (NYSE:CC), if they purchased the Company's shares between February 16, 2017 and August 1, 2019, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Delaware.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
www.ksfcounsel.com to learn more about KSF. (PRNewsfoto/Kahn Swick & Foti, LLC)">
What You May Do
If you purchased shares of Chemours and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-cc/ to learn more. If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by December 9, 2019 .
About the Lawsuit
On August 1, 2019, post-market, the Company disclosed negative financial results for 2Q2019 including decreases in earnings and revenue, a reduction to full-year free cash flow outlook to $100 million from prior guidance of over $550 million, and significant increases in estimated environmental liabilities, including over a dozen new legal and regulatory actions related to toxic perfluoroalkyl and polyfluoroalkyl substances.
On this news, the price of Chemours' shares plummeted 19% from $18.16 per share on August 1, 2019 to $14.69 on August 2, 2019 on unusually high volume, erasing over $560 million in shareholder value.
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
The case is Electrical Workers Pension Fund, Local 103, I.B.E.W. v. The Chemours Company, 19-cv-01911.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163
SOURCE Kahn Swick & Foti, LLC
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.